The latest biotech news

News and Trends 23 Jun 2015

Will Boehringer Ingelheim win the race for anticoagulants?

Boehringer Ingelheim has released the last figures of its idarucizumab Phase III. The breakthrough anti-anticoagulant is being studied as an antidote to Boehringer’s blockbuster Pradaxa. Pradaxa was the first widely approved drug in a new generation of direct oral anticoagulants, a blockbuster developed by Boehringer Ingelheim. However, there is no specific antidote available yet to […]

June 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Jun 2015

Kamada and Baxter extend their collaboration in Lung Transplant

The Israeli biotech Kamada and Baxalta, Baxter’ subsidiary will jointly co-fund a trial test to find out whether Kamada’s candidate is capable of preventing lung transplant rejection. Kamada, a plasma-derived protein therapeutics company focused on orphan indications, will carry out a Phase I/II clinical trial of its candidate alpha-1 antirypsin (AAT). The protein was already approved for […]

June 22, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 22 Jun 2015

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Each year, BIO Philadelphia awards the Everyday Superheroes of Biotech Industry. Here’s the story of Bernard Muller, co-founder of Treeway, a Dutch biotech company focused on the treatment of Amyotrophic lateral sclerosis (ALS). Bernard Muller is an extraordinary person, being himself a ALS patient and an entrepreneur who started his own Biotech company. Last week, we were talking […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 22 Jun 2015

Medigene plans to fund its T-cell program with €50 Millions

Munich-based Medigene is planning to raise cash through existing shareholders’ investments. The company targets up to €50M to propel its immune-oncology program with T-Cell Receptors and Dendritic Cells vaccines assets. Medigene plans a cash capital increase with subscription rights for existing shareholders by offering a new batch of shares. The company is going to present […]

June 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Jun 2015

American Companies are Invading London’s Biotech Stock Market

[Update: On June 19, Puretech successfully raised $171M – approximately €150M – during its IPO, setting its market cap at €509M] Boston-based PureTech Health plans to raise €147M on the London stock market, following the path of Verseon, a San Diego-based bioinformatic company that raised €92M earlier this month. Is there a new American trend to earn cash in […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Jun 2015

Biotech to Revolutionize the Millennial Production of Carmine!

The Danish company Chr Hansen, through a partnership with the University of Copenhagen, created a process able to produce carmine dye by fermentation. Thanks to this discovery, the company is disrupting a millennial production method and stepping up to the plate, becoming a real game changer. With its particular deep-red color, carmine is one of the most […]

June 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Jun 2015

BIO2015: Over and Out!

Three is the magic number as they say… After bringing you the highlights of the first and second day of the biggest Biotech Convention worldwide, we couldn’t give up on you so close from the end. So without further ado, here’s the summary of day three. Katrine Bosley, CEO of Editas, hosted Arnt Schottelius from MorphoSys, Loredana Ablondi, […]

June 19, 2015 - 3 minutesmins - By Alexandre Lowrey

News and Trends 19 Jun 2015

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

[UPDATE 19/06/2015]: Yesterday, Celyad launched its IPO on NASDAQ and the closing is expected to occur on 24 June 2015. Celyad, formely known as Cardio3, is preparing to cross the Atlantic to launch an IPO on NASDAQ. The company, which is already listed on Euronext Paris and Euronext Brussels, aims to raise €103.2M ($115 million) on […]

June 19, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 19 Jun 2015

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

Servier is fattening up its oncology assests with the acquisition of Taiho Pharmaceutical’s treatment of refractory mestatic colorectal cancer. The French laboratories will commercialize the molecule in Europe and other countries. Taiho Pharmaceutical and Servier come to an agreement for the development and commercialization of TAS-102 in Europe. The drug is an oral combination anticancer drug […]

June 19, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Jun 2015

BIO2015: The Marathon Keeps On Going!

Yesterday, we covered the launch of the biggest Biotech event worldwide, currently taking place in Philadelphia. And you guessed it, we’re not going to leave you in the dark of this incredible convention, so get comfy and catch up with a few of the highlights of the second day. Wednesday started off with an interesting […]

June 18, 2015 - 3 minutesmins - By Alexandre Lowrey

News and Trends 18 Jun 2015

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its US presence and benefit from Boston’s leading position in the gene therapy field. Gene Therapy is the next big thing in Biotech and is now moving from a theoretical dream to reality. Boston is clearly the hotspot for […]

June 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Jun 2015

Innovate UK accelerates Sareum’s fight against Leukemia

Innovate UK, the country’s innovation agency, keeps promoting technology in the British islands. The latest beneficiary is Sareum, a cancer specialist biotech with a strong autoimmune disease programme. The company received €195.5k to fight an early-age type of leukaemia. T-Cell Acute Lymphoblastic Leukaemia is a rare type of leukaemia that most often occurs in late […]

June 17, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Will Boehringer Ingelheim win the race for anticoagulants?

Kamada and Baxter extend their collaboration in Lung Transplant

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Medigene plans to fund its T-cell program with €50 Millions

American Companies are Invading London’s Biotech Stock Market

Biotech to Revolutionize the Millennial Production of Carmine!

BIO2015: Over and Out!

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

BIO2015: The Marathon Keeps On Going!

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

Innovate UK accelerates Sareum’s fight against Leukemia

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!